Sandoz Group AG (OTCMKTS:SDZNY – Get Free Report)’s stock price hit a new 52-week high on Thursday . The company traded as high as $47.96 and last traded at $47.76, with a volume of 26618 shares. The stock had previously closed at $46.85.
Analyst Upgrades and Downgrades
Separately, BNP Paribas downgraded Sandoz Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, December 2nd.
Check Out Our Latest Stock Report on SDZNY
Sandoz Group Price Performance
Sandoz Group Company Profile
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.
Read More
- Five stocks we like better than Sandoz Group
- 5 Top Rated Dividend Stocks to Consider
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
- 3 Small Caps With Big Return Potential
- Microsoft and Meta’s AI Investment Plans Are Full Steam Ahead
- Comparing and Trading High PE Ratio Stocks
- Beyond Self-Driving Cars: Factory Automation Takes Center Stage
Receive News & Ratings for Sandoz Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sandoz Group and related companies with MarketBeat.com's FREE daily email newsletter.
